Global Clinical Trial Packaging Market By Clinical Phase (Phase 1, Phase 2, Phase 3, Phase 4); By Type (Primary Packaging – Blistering, Bottling, Pouching, Tubing, Sterile fill finish, Aseptic fill, Others, Secondary Packaging – Cartoning, Overwraping, Walleting, Labelling, Kit assembly, Others); By Material (Plastic – PVC, PE, HDPE, LDPE, PP, Others, Glass, Paper, Others); By End Users (Research Laboratories, Clinical Research Organizations, Drug Manufacturing Facilities, Biotechnology Companies); By Region (Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2023 – 2031
Industry Trends
Clinical trials happen to be the prospective biomedical or behavioural research studies conducted on human participants that helps in getting answers for certain type of questions regarding the biomedical or behavioural interventions that is inclusive of latest type of treatments along with known interventions that require or demand further study and point of distinction. Clinical trials are utterly helpful in generating data regarding dosage, safety and efficacy of any product. This is because these clinical trials are conducted only after receiving approval from the regulating health organizations. These authorities take full responsibility for only regarding conducting the trials but not in regards with the efficacy. In wake of changing global conditions on healthcare level, the clinical trial are being conducted extensively as these trials are likely to vary in size and cost, and they are likely to involve a single research center or numerous centers, in one nation or in several nations. These study designs are used to understand multiple aspects of any drug. The world saw a surge in the number of clinical trials during the coronavirus pandemic. This was because the society needed answers for various questions and to seek solution for life-threatening disease that claimed lives for millions of people. This is why the global clinical trial packaging market grew despite the adverse situations.
In terms of revenue, the global clinical trial packaging market was worth US$ 3.10 Bn in 2022 growing at a CAGR of 10.2% over the forecast period (2023 – 2031). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Type Outlook
Based on the type outlook, the global clinical trial packaging market has been bifurcated into primary packaging and secondary packaging. The primary packaging segment has been bifurcated into blistering, bottling, pouching, tubing, sterile fill finish, aseptic fill and others. While the secondary packaging segment is divided into cartooning, overwrapping, walleting, labelling, kit assembly and others. The pouching segment accounts for majority of revenue generated by this market. This is because of the Importance of pouching in storing samples of any drug or medicine.
Region Outlook
On the basis of the region, the continent of North America has been dominating in terms of revenue generation for the global clinical trial packaging market in the year 2022. Even before the pandemic happened, the countries of the United States and Canada were home to leading drug makers, medical research companies and pharma companies in this world. Heavy investments to procure newer type of treatments, clinical trials are needed and this is why the market is growing.
Competitive Landscape
The report provides both, qualitative and quantitative research of global clinical trial packaging market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the key participants operating in the global clinical trial packaging market are:
- 3M
- Almac Group Limited
- Bilcare Limited
- Caligor Coghlan
- Capsugel Belgium NV
- Clinigen Clinical Supplies Management
- Korber AG
- NextPharma Technologies
- PCI Pharma Services
- Piramal Pharma Services
- Sharp Services, LLC
- Westrock Company
- Xerimis
- Other Market Participants
Global Clinical Trial Packaging Market:
By Clinical Phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
By Type
- Primary Packaging
- Blistering
- Bottling
- Pouching
- Tubing
- Sterile fill finish
- Aseptic fill
- Others
- Secondary Packaging
- Cartoning
- Overwrapping
- Walleting
- Labelling
- Kit assembly
- Others
By Material
- Plastic
- PVC
- PE
- HDPE
- LDPE
- PP
- Others
- Glass
- Paper
- Others
By End Users
- Research Laboratories
- Clinical Research Organizations
- Drug Manufacturing Facilities
- Biotechnology Companies
By Region
- North America (U.S., Canada, Mexico, Rest of North America)
- Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe
- Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific
- Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
- Latin America (Brazil, Argentina, Rest of Latin America)
Table of Contents
1.
Market
Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1. Historic Years: 2015 – 2021
1.2.2. Base Year: 2022
1.2.3. Forecast Years: 2023 - 2031
2.
Key
Target Audiences
3.
Research
Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2. Global Percentage Breakdown
3.1.3. Primary Interviews: Key Opinion Leaders
(KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4.
Recommendations
and Insights from AMI’s Perspective**
5.
Holistic
Overview of Clinical Trial Packaging
Market
6.
Market
Synopsis: Clinical Trial Packaging Market
7.
Clinical
Trial Packaging Market Analysis:
Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in Clinical Trial Packaging Market
7.4. Market Determinants Radar Chart
7.5. Macro-Economic and Micro-Economic Indicators:
Clinical Trial Packaging Market
7.6. Porter’s Five Force Analysis
7.7. Impact of Covid-19 on Clinical Trial
Packaging Market
8.
Global
Clinical Trial Packaging Market Analysis and Forecasts, 2023 - 2031
8.1. Overview
8.1.1. Global Clinical Trial Packaging Market
Revenue (US$ Mn)
8.2. Global Clinical Trial Packaging Market
Revenue (US$ Mn) and Forecasts, By Clinical Phase
8.2.1. Phase 1
8.2.1.1.
Definition
8.2.1.2.
Market
Estimation and Penetration, 2015 - 2022
8.2.1.3.
Market
Forecast, 2023 - 2031
8.2.1.4.
Compound
Annual Growth Rate (CAGR)
8.2.1.5.
Regional
Bifurcation
8.2.1.5.1.
North
America
8.2.1.5.1.1. Market Estimation, 2015 - 2022
8.2.1.5.1.2. Market Forecast, 2023 - 2031
8.2.1.5.2.
Europe
8.2.1.5.2.1. Market Estimation, 2015 - 2022
8.2.1.5.2.2. Market Forecast, 2023 - 2031
8.2.1.5.3.
Asia
Pacific
8.2.1.5.3.1. Market Estimation, 2015 - 2022
8.2.1.5.3.2. Market Forecast, 2023 - 2031
8.2.1.5.4.
Middle
East and Africa
8.2.1.5.4.1. Market Estimation, 2015 - 2022
8.2.1.5.4.2. Market Forecast, 2023 - 2031
8.2.1.5.5.
Latin
America
8.2.1.5.5.1. Market Estimation, 2015 - 2022
8.2.1.5.5.2. Market Forecast, 2023 - 2031
8.2.2. Phase 2
8.2.2.1.
Definition
8.2.2.2.
Market
Estimation and Penetration, 2015 - 2022
8.2.2.3.
Market
Forecast, 2023 - 2031
8.2.2.4.
Compound
Annual Growth Rate (CAGR)
8.2.2.5.
Regional
Bifurcation
8.2.2.5.1.
North
America
8.2.2.5.1.1. Market Estimation, 2015 - 2022
8.2.2.5.1.2. Market Forecast, 2023 - 2031
8.2.2.5.2.
Europe
8.2.2.5.2.1. Market Estimation, 2015 - 2022
8.2.2.5.2.2. Market Forecast, 2023 - 2031
8.2.2.5.3.
Asia
Pacific
8.2.2.5.3.1. Market Estimation, 2015 - 2022
8.2.2.5.3.2. Market Forecast, 2023 - 2031
8.2.2.5.4.
Middle
East and Africa
8.2.2.5.4.1. Market Estimation, 2015 - 2022
8.2.2.5.4.2. Market Forecast, 2023 - 2031
8.2.2.5.5.
Latin
America
8.2.2.5.5.1. Market Estimation, 2015 - 2022
8.2.2.5.5.2. Market Forecast, 2023 - 2031
8.2.3. Phase 3
8.2.3.1.
Definition
8.2.3.2.
Market
Estimation and Penetration, 2015 - 2022
8.2.3.3.
Market
Forecast, 2023 - 2031
8.2.3.4.
Compound
Annual Growth Rate (CAGR)
8.2.3.5.
Regional
Bifurcation
8.2.3.5.1.
North
America
8.2.3.5.1.1. Market Estimation, 2015 - 2022
8.2.3.5.1.2. Market Forecast, 2023 - 2031
8.2.3.5.2.
Europe
8.2.3.5.2.1. Market Estimation, 2015 - 2022
8.2.3.5.2.2. Market Forecast, 2023 - 2031
8.2.3.5.3.
Asia
Pacific
8.2.3.5.3.1. Market Estimation, 2015 - 2022
8.2.3.5.3.2. Market Forecast, 2023 - 2031
8.2.3.5.4.
Middle
East and Africa
8.2.3.5.4.1. Market Estimation, 2015 - 2022
8.2.3.5.4.2. Market Forecast, 2023 - 2031
8.2.3.5.5.
Latin
America
8.2.3.5.5.1. Market Estimation, 2015 - 2022
8.2.3.5.5.2. Market Forecast, 2023 - 2031
8.2.4. Phase 4
8.2.4.1.
Definition
8.2.4.2.
Market
Estimation and Penetration, 2015 - 2022
8.2.4.3.
Market
Forecast, 2023 - 2031
8.2.4.4.
Compound
Annual Growth Rate (CAGR)
8.2.4.5.
Regional
Bifurcation
8.2.4.5.1.
North
America
8.2.4.5.1.1. Market Estimation, 2015 - 2022
8.2.4.5.1.2. Market Forecast, 2023 - 2031
8.2.4.5.2.
Europe
8.2.4.5.2.1. Market Estimation, 2015 - 2022
8.2.4.5.2.2. Market Forecast, 2023 - 2031
8.2.4.5.3.
Asia
Pacific
8.2.4.5.3.1. Market Estimation, 2015 - 2022
8.2.4.5.3.2. Market Forecast, 2023 - 2031
8.2.4.5.4.
Middle
East and Africa
8.2.4.5.4.1. Market Estimation, 2015 - 2022
8.2.4.5.4.2. Market Forecast, 2023 - 2031
8.2.4.5.5.
Latin
America
8.2.4.5.5.1. Market Estimation, 2015 - 2022
8.2.4.5.5.2. Market Forecast, 2023 - 2031
8.3. Key Segment for Channeling Investments
8.3.1. By Clinical Phase
9.
Global
Clinical Trial Packaging Market Analysis and Forecasts, 2023 - 2031
9.1. Overview
9.2. Global Clinical Trial Packaging Market
Revenue (US$ Mn) and Forecasts, By Type
9.2.1. Primary Packaging (Definition, Market Estimation and
Penetration, 2015 - 2022, Market Estimation (2015 - 2022), Market Forecast
(2023 - 2031), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and
Information on Blistering, Bottling, Pouching, Tubing, Sterile fill finish ,
Aseptic fill , Others )
9.2.1.1.
Blistering
9.2.1.2.
Bottling
9.2.1.3.
Pouching
9.2.1.4.
Tubing
9.2.1.5.
Sterile
fill finish
9.2.1.6.
Aseptic
fill
9.2.1.7.
Others
9.2.2. Secondary Packaging (Definition, Market Estimation and
Penetration, 2015 - 2022, Market Estimation (2015 - 2022), Market Forecast
(2023 - 2031), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and
Information on Cartoning, Overwrapping , Walleting, Labelling, Kit assembly ,
Others )
9.2.2.1.
Cartoning
9.2.2.2.
Overwrapping
9.2.2.3.
Walleting
9.2.2.4.
Labelling
9.2.2.5.
Kit assembly
9.2.2.6.
Others
9.3. Key Segment for Channeling Investments
9.3.1. By Type
10. Global Clinical Trial Packaging Market
Analysis and Forecasts, 2023 - 2031
10.1. Overview
10.2. Global Clinical Trial Packaging Market
Revenue (US$ Mn) and Forecasts, By Material
10.2.1. Plastic (Definition, Market Estimation and
Penetration, 2015 - 2022, Market Estimation (2015 - 2022), Market Forecast
(2023 - 2031), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and
Information on PVC, PE, HDPE, LDPE, PP, Others)
10.2.1.1. PVC
10.2.1.2. PE
10.2.1.3. HDPE
10.2.1.4. LDPE
10.2.1.5. PP
10.2.1.6. Others
10.2.2. Glass
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 -
2022
10.2.2.3. Market Forecast, 2023 - 2031
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market Estimation, 2015 - 2022
10.2.2.5.1.2. Market Forecast, 2023 - 2031
10.2.2.5.2. Europe
10.2.2.5.2.1. Market Estimation, 2015 - 2022
10.2.2.5.2.2. Market Forecast, 2023 - 2031
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market Estimation, 2015 - 2022
10.2.2.5.3.2. Market Forecast, 2023 - 2031
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market Estimation, 2015 - 2022
10.2.2.5.4.2. Market Forecast, 2023 - 2031
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market Estimation, 2015 - 2022
10.2.2.5.5.2. Market Forecast, 2023 - 2031
10.2.3. Paper
10.2.3.1. Definition
10.2.3.2. Market Estimation and Penetration, 2015 -
2022
10.2.3.3. Market Forecast, 2023 - 2031
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. North America
10.2.3.5.1.1. Market Estimation, 2015 - 2022
10.2.3.5.1.2. Market Forecast, 2023 - 2031
10.2.3.5.2. Europe
10.2.3.5.2.1. Market Estimation, 2015 - 2022
10.2.3.5.2.2. Market Forecast, 2023 - 2031
10.2.3.5.3. Asia Pacific
10.2.3.5.3.1. Market Estimation, 2015 - 2022
10.2.3.5.3.2. Market Forecast, 2023 - 2031
10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1. Market Estimation, 2015 - 2022
10.2.3.5.4.2. Market Forecast, 2023 - 2031
10.2.3.5.5. Latin America
10.2.3.5.5.1. Market Estimation, 2015 - 2022
10.2.3.5.5.2. Market Forecast, 2023 - 2031
10.2.4. Others
10.2.4.1. Definition
10.2.4.2. Market Estimation and Penetration, 2015 -
2022
10.2.4.3. Market Forecast, 2023 - 2031
10.2.4.4. Compound Annual Growth Rate (CAGR)
10.2.4.5. Regional Bifurcation
10.2.4.5.1. North America
10.2.4.5.1.1. Market Estimation, 2015 - 2022
10.2.4.5.1.2. Market Forecast, 2023 - 2031
10.2.4.5.2. Europe
10.2.4.5.2.1. Market Estimation, 2015 - 2022
10.2.4.5.2.2. Market Forecast, 2023 - 2031
10.2.4.5.3. Asia Pacific
10.2.4.5.3.1. Market Estimation, 2015 - 2022
10.2.4.5.3.2. Market Forecast, 2023 - 2031
10.2.4.5.4. Middle East and Africa
10.2.4.5.4.1. Market Estimation, 2015 - 2022
10.2.4.5.4.2. Market Forecast, 2023 - 2031
10.2.4.5.5. Latin America
10.2.4.5.5.1. Market Estimation, 2015 - 2022
10.2.4.5.5.2. Market Forecast, 2023 - 2031
10.3. Key Segment for Channeling Investments
10.3.1. By Material
11. Global Clinical Trial Packaging Market
Analysis and Forecasts, 2023 - 2031
11.1. Overview
11.2. Global Clinical Trial Packaging Market
Revenue (US$ Mn) and Forecasts, By End User
11.2.1. Research Laboratories
11.2.1.1. Definition
11.2.1.2. Market Estimation and Penetration, 2015 -
2022
11.2.1.3. Market Forecast, 2023 - 2031
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1. North America
11.2.1.5.1.1. Market Estimation, 2015 - 2022
11.2.1.5.1.2. Market Forecast, 2023 - 2031
11.2.1.5.2. Europe
11.2.1.5.2.1. Market Estimation, 2015 - 2022
11.2.1.5.2.2. Market Forecast, 2023 - 2031
11.2.1.5.3. Asia Pacific
11.2.1.5.3.1. Market Estimation, 2015 - 2022
11.2.1.5.3.2. Market Forecast, 2023 - 2031
11.2.1.5.4. Middle East and Africa
11.2.1.5.4.1. Market Estimation, 2015 - 2022
11.2.1.5.4.2. Market Forecast, 2023 - 2031
11.2.1.5.5. Latin America
11.2.1.5.5.1. Market Estimation, 2015 - 2022
11.2.1.5.5.2. Market Forecast, 2023 - 2031
11.2.2. Clinical Research Organizations
11.2.2.1. Definition
11.2.2.2. Market Estimation and Penetration, 2015 -
2022
11.2.2.3. Market Forecast, 2023 - 2031
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1. North America
11.2.2.5.1.1. Market Estimation, 2015 - 2022
11.2.2.5.1.2. Market Forecast, 2023 - 2031
11.2.2.5.2. Europe
11.2.2.5.2.1. Market Estimation, 2015 - 2022
11.2.2.5.2.2. Market Forecast, 2023 - 2031
11.2.2.5.3. Asia Pacific
11.2.2.5.3.1. Market Estimation, 2015 - 2022
11.2.2.5.3.2. Market Forecast, 2023 - 2031
11.2.2.5.4. Middle East and Africa
11.2.2.5.4.1. Market Estimation, 2015 - 2022
11.2.2.5.4.2. Market Forecast, 2023 - 2031
11.2.2.5.5. Latin America
11.2.2.5.5.1. Market Estimation, 2015 - 2022
11.2.2.5.5.2. Market Forecast, 2023 - 2031
11.2.3. Drug Manufacturing Facilities
11.2.3.1. Definition
11.2.3.2. Market Estimation and Penetration, 2015 -
2022
11.2.3.3. Market Forecast, 2023 - 2031
11.2.3.4. Compound Annual Growth Rate (CAGR)
11.2.3.5. Regional Bifurcation
11.2.3.5.1. North America
11.2.3.5.1.1. Market Estimation, 2015 - 2022
11.2.3.5.1.2. Market Forecast, 2023 - 2031
11.2.3.5.2. Europe
11.2.3.5.2.1. Market Estimation, 2015 - 2022
11.2.3.5.2.2. Market Forecast, 2023 - 2031
11.2.3.5.3. Asia Pacific
11.2.3.5.3.1. Market Estimation, 2015 - 2022
11.2.3.5.3.2. Market Forecast, 2023 - 2031
11.2.3.5.4. Middle East and Africa
11.2.3.5.4.1. Market Estimation, 2015 - 2022
11.2.3.5.4.2. Market Forecast, 2023 - 2031
11.2.3.5.5. Latin America
11.2.3.5.5.1. Market Estimation, 2015 - 2022
11.2.3.5.5.2. Market Forecast, 2023 - 2031
11.2.4. Biotechnology Companies
11.2.4.1. Definition
11.2.4.2. Market Estimation and Penetration, 2015 -
2022
11.2.4.3. Market Forecast, 2023 - 2031
11.2.4.4. Compound Annual Growth Rate (CAGR)
11.2.4.5. Regional Bifurcation
11.2.4.5.1. North America
11.2.4.5.1.1. Market Estimation, 2015 - 2022
11.2.4.5.1.2. Market Forecast, 2023 - 2031
11.2.4.5.2. Europe
11.2.4.5.2.1. Market Estimation, 2015 - 2022
11.2.4.5.2.2. Market Forecast, 2023 - 2031
11.2.4.5.3. Asia Pacific
11.2.4.5.3.1. Market Estimation, 2015 - 2022
11.2.4.5.3.2. Market Forecast, 2023 - 2031
11.2.4.5.4. Middle East and Africa
11.2.4.5.4.1. Market Estimation, 2015 - 2022
11.2.4.5.4.2. Market Forecast, 2023 - 2031
11.2.4.5.5. Latin America
11.2.4.5.5.1. Market Estimation, 2015 - 2022
11.2.4.5.5.2. Market Forecast, 2023 - 2031
11.3. Key Segment for Channeling Investments
11.3.1. By End User
12. North America Clinical Trial Packaging Market Analysis and Forecasts, 2023 - 2031
12.1. Overview
12.1.1. North America Clinical Trial Packaging Market Revenue (US$ Mn)
12.2. North America Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Clinical Phase
12.2.1. Phase 1
12.2.2. Phase 2
12.2.3. Phase 3
12.2.4. Phase 4
12.3. North America Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Type
12.3.1. Primary Packaging
12.3.1.1. Blistering
12.3.1.2. Bottling
12.3.1.3. Pouching
12.3.1.4. Tubing
12.3.1.5. Sterile fill finish
12.3.1.6. Aseptic fill
12.3.1.7. Others
12.3.2. Secondary Packaging
12.3.2.1. Cartoning
12.3.2.2. Overwrapping
12.3.2.3. Walleting
12.3.2.4. Labelling
12.3.2.5. Kit assembly
12.3.2.6. Others
12.4. North America Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Material
12.4.1. Plastic
12.4.1.1. PVC
12.4.1.2. PE
12.4.1.3. HDPE
12.4.1.4. LDPE
12.4.1.5. PP
12.4.1.6. Others
12.4.2. Glass
12.4.3. Paper
12.4.4. Others
12.5. North America Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By End
User
12.5.1. Research Laboratories
12.5.2. Clinical Research Organizations
12.5.3. Drug Manufacturing Facilities
12.5.4. Biotechnology Companies
12.6. North America Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Country
12.6.1. U.S
12.6.1.1. U.S Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Clinical Phase
12.6.1.1.1. Phase 1
12.6.1.1.2. Phase 2
12.6.1.1.3. Phase 3
12.6.1.1.4. Phase 4
12.6.1.2. U.S Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Type
12.6.1.2.1. Primary Packaging
12.6.1.2.1.1. Blistering
12.6.1.2.1.2. Bottling
12.6.1.2.1.3. Pouching
12.6.1.2.1.4. Tubing
12.6.1.2.1.5. Sterile fill finish
12.6.1.2.1.6. Aseptic fill
12.6.1.2.1.7. Others
12.6.1.2.2. Secondary Packaging
12.6.1.2.2.1. Cartoning
12.6.1.2.2.2. Overwrapping
12.6.1.2.2.3. Walleting
12.6.1.2.2.4. Labelling
12.6.1.2.2.5. Kit assembly
12.6.1.2.2.6. Others
12.6.1.3. U.S Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Material
12.6.1.3.1. Plastic
12.6.1.3.1.1. PVC
12.6.1.3.1.2. PE
12.6.1.3.1.3. HDPE
12.6.1.3.1.4. LDPE
12.6.1.3.1.5. PP
12.6.1.3.1.6. Others
12.6.1.3.2. Glass
12.6.1.3.3. Paper
12.6.1.3.4. Others
12.6.1.4. U.S Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By End
User
12.6.1.4.1. Research Laboratories
12.6.1.4.2. Clinical Research Organizations
12.6.1.4.3. Drug Manufacturing Facilities
12.6.1.4.4. Biotechnology Companies
12.6.2. Canada
12.6.2.1. Canada Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Clinical Phase
12.6.2.1.1. Phase 1
12.6.2.1.2. Phase 2
12.6.2.1.3. Phase 3
12.6.2.1.4. Phase 4
12.6.2.2. Canada Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Type
12.6.2.2.1. Primary Packaging
12.6.2.2.1.1. Blistering
12.6.2.2.1.2. Bottling
12.6.2.2.1.3. Pouching
12.6.2.2.1.4. Tubing
12.6.2.2.1.5. Sterile fill finish
12.6.2.2.1.6. Aseptic fill
12.6.2.2.1.7. Others
12.6.2.2.2. Secondary Packaging
12.6.2.2.2.1. Cartoning
12.6.2.2.2.2. Overwrapping
12.6.2.2.2.3. Walleting
12.6.2.2.2.4. Labelling
12.6.2.2.2.5. Kit assembly
12.6.2.2.2.6. Others
12.6.2.3. Canada Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Material
12.6.2.3.1. Plastic
12.6.2.3.1.1. PVC
12.6.2.3.1.2. PE
12.6.2.3.1.3. HDPE
12.6.2.3.1.4. LDPE
12.6.2.3.1.5. PP
12.6.2.3.1.6. Others
12.6.2.3.2. Glass
12.6.2.3.3. Paper
12.6.2.3.4. Others
12.6.2.4. Canada Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By End
User
12.6.2.4.1. Research Laboratories
12.6.2.4.2. Clinical Research Organizations
12.6.2.4.3. Drug Manufacturing Facilities
12.6.2.4.4. Biotechnology Companies
12.6.3. Mexico
12.6.3.1. Mexico Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Clinical Phase
12.6.3.1.1. Phase 1
12.6.3.1.2. Phase 2
12.6.3.1.3. Phase 3
12.6.3.1.4. Phase 4
12.6.3.2. Mexico Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Type
12.6.3.2.1. Primary Packaging
12.6.3.2.1.1. Blistering
12.6.3.2.1.2. Bottling
12.6.3.2.1.3. Pouching
12.6.3.2.1.4. Tubing
12.6.3.2.1.5. Sterile fill finish
12.6.3.2.1.6. Aseptic fill
12.6.3.2.1.7. Others
12.6.3.2.2. Secondary Packaging
12.6.3.2.2.1. Cartoning
12.6.3.2.2.2. Overwrapping
12.6.3.2.2.3. Walleting
12.6.3.2.2.4. Labelling
12.6.3.2.2.5. Kit assembly
12.6.3.2.2.6. Others
12.6.3.3. Mexico Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Material
12.6.3.3.1. Plastic
12.6.3.3.1.1. PVC
12.6.3.3.1.2. PE
12.6.3.3.1.3. HDPE
12.6.3.3.1.4. LDPE
12.6.3.3.1.5. PP
12.6.3.3.1.6. Others
12.6.3.3.2. Glass
12.6.3.3.3. Paper
12.6.3.3.4. Others
12.6.3.4. Mexico Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By End
User
12.6.3.4.1. Research Laboratories
12.6.3.4.2. Clinical Research Organizations
12.6.3.4.3. Drug Manufacturing Facilities
12.6.3.4.4. Biotechnology Companies
12.6.4. Rest of North America
12.6.4.1. Rest of North America Clinical Trial
Packaging Market Revenue (US$ Mn) and
Forecasts, By Clinical Phase
12.6.4.1.1. Phase 1
12.6.4.1.2. Phase 2
12.6.4.1.3. Phase 3
12.6.4.1.4. Phase 4
12.6.4.2. Rest of North America Clinical Trial
Packaging Market Revenue (US$ Mn) and
Forecasts, By Type
12.6.4.2.1. Primary Packaging
12.6.4.2.1.1. Blistering
12.6.4.2.1.2. Bottling
12.6.4.2.1.3. Pouching
12.6.4.2.1.4. Tubing
12.6.4.2.1.5. Sterile fill finish
12.6.4.2.1.6. Aseptic fill
12.6.4.2.1.7. Others
12.6.4.2.2. Secondary Packaging
12.6.4.2.2.1. Cartoning
12.6.4.2.2.2. Overwrapping
12.6.4.2.2.3. Walleting
12.6.4.2.2.4. Labelling
12.6.4.2.2.5. Kit assembly
12.6.4.2.2.6. Others
12.6.4.3. Rest of North America Clinical Trial
Packaging Market Revenue (US$ Mn) and
Forecasts, By Material
12.6.4.3.1. Plastic
12.6.4.3.1.1. PVC
12.6.4.3.1.2. PE
12.6.4.3.1.3. HDPE
12.6.4.3.1.4. LDPE
12.6.4.3.1.5. PP
12.6.4.3.1.6. Others
12.6.4.3.2. Glass
12.6.4.3.3. Paper
12.6.4.3.4. Others
12.6.4.4. Rest of North America Clinical Trial
Packaging Market Revenue (US$ Mn) and
Forecasts, By End User
12.6.4.4.1. Research Laboratories
12.6.4.4.2. Clinical Research Organizations
12.6.4.4.3. Drug Manufacturing Facilities
12.6.4.4.4. Biotechnology Companies
12.7. Key Segment for Channeling Investments
12.7.1. By Country
12.7.2. By Clinical Phase
12.7.3. By Type
12.7.4. By Material
12.7.5. By End User
13. Europe Clinical Trial Packaging Market Analysis and Forecasts, 2023 - 2031
13.1. Overview
13.1.1. Europe Clinical Trial Packaging Market Revenue (US$ Mn)
13.2. Europe Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Clinical Phase
13.2.1. Phase 1
13.2.2. Phase 2
13.2.3. Phase 3
13.2.4. Phase 4
13.3. Europe Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Type
13.3.1. Primary Packaging
13.3.1.1. Blistering
13.3.1.2. Bottling
13.3.1.3. Pouching
13.3.1.4. Tubing
13.3.1.5. Sterile fill finish
13.3.1.6. Aseptic fill
13.3.1.7. Others
13.3.2. Secondary Packaging
13.3.2.1. Cartoning
13.3.2.2. Overwrapping
13.3.2.3. Walleting
13.3.2.4. Labelling
13.3.2.5. Kit assembly
13.3.2.6. Others
13.4. Europe Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Material
13.4.1. Plastic
13.4.1.1. PVC
13.4.1.2. PE
13.4.1.3. HDPE
13.4.1.4. LDPE
13.4.1.5. PP
13.4.1.6. Others
13.4.2. Glass
13.4.3. Paper
13.4.4. Others
13.5. Europe Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By End
User
13.5.1. Research Laboratories
13.5.2. Clinical Research Organizations
13.5.3. Drug Manufacturing Facilities
13.5.4. Biotechnology Companies
13.6. Europe Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Country
13.6.1. France
13.6.1.1. France Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Clinical Phase
13.6.1.1.1. Phase 1
13.6.1.1.2. Phase 2
13.6.1.1.3. Phase 3
13.6.1.1.4. Phase 4
13.6.1.2. France Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Type
13.6.1.2.1. Primary Packaging
13.6.1.2.1.1. Blistering
13.6.1.2.1.2. Bottling
13.6.1.2.1.3. Pouching
13.6.1.2.1.4. Tubing
13.6.1.2.1.5. Sterile fill finish
13.6.1.2.1.6. Aseptic fill
13.6.1.2.1.7. Others
13.6.1.2.2. Secondary Packaging
13.6.1.2.2.1. Cartoning
13.6.1.2.2.2. Overwrapping
13.6.1.2.2.3. Walleting
13.6.1.2.2.4. Labelling
13.6.1.2.2.5. Kit assembly
13.6.1.2.2.6. Others
13.6.1.3. France Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Material
13.6.1.3.1. Plastic
13.6.1.3.1.1. PVC
13.6.1.3.1.2. PE
13.6.1.3.1.3. HDPE
13.6.1.3.1.4. LDPE
13.6.1.3.1.5. PP
13.6.1.3.1.6. Others
13.6.1.3.2. Glass
13.6.1.3.3. Paper
13.6.1.3.4. Others
13.6.1.4. France Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By End
User
13.6.1.4.1. Research Laboratories
13.6.1.4.2. Clinical Research Organizations
13.6.1.4.3. Drug Manufacturing Facilities
13.6.1.4.4. Biotechnology Companies
13.6.2. The UK
13.6.2.1. The UK Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Clinical Phase
13.6.2.1.1. Phase 1
13.6.2.1.2. Phase 2
13.6.2.1.3. Phase 3
13.6.2.1.4. Phase 4
13.6.2.2. The UK Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Type
13.6.2.2.1. Primary Packaging
13.6.2.2.1.1. Blistering
13.6.2.2.1.2. Bottling
13.6.2.2.1.3. Pouching
13.6.2.2.1.4. Tubing
13.6.2.2.1.5. Sterile fill finish
13.6.2.2.1.6. Aseptic fill
13.6.2.2.1.7. Others
13.6.2.2.2. Secondary Packaging
13.6.2.2.2.1. Cartoning
13.6.2.2.2.2. Overwrapping
13.6.2.2.2.3. Walleting
13.6.2.2.2.4. Labelling
13.6.2.2.2.5. Kit assembly
13.6.2.2.2.6. Others
13.6.2.3. The UK Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Material
13.6.2.3.1. Plastic
13.6.2.3.1.1. PVC
13.6.2.3.1.2. PE
13.6.2.3.1.3. HDPE
13.6.2.3.1.4. LDPE
13.6.2.3.1.5. PP
13.6.2.3.1.6. Others
13.6.2.3.2. Glass
13.6.2.3.3. Paper
13.6.2.3.4. Others
13.6.2.4. The UK Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By End
User
13.6.2.4.1. Research Laboratories
13.6.2.4.2. Clinical Research Organizations
13.6.2.4.3. Drug Manufacturing Facilities
13.6.2.4.4. Biotechnology Companies
13.6.3. Spain
13.6.3.1. Spain Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Clinical Phase
13.6.3.1.1. Phase 1
13.6.3.1.2. Phase 2
13.6.3.1.3. Phase 3
13.6.3.1.4. Phase 4
13.6.3.2. Spain Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Type
13.6.3.2.1. Primary Packaging
13.6.3.2.1.1. Blistering
13.6.3.2.1.2. Bottling
13.6.3.2.1.3. Pouching
13.6.3.2.1.4. Tubing
13.6.3.2.1.5. Sterile fill finish
13.6.3.2.1.6. Aseptic fill
13.6.3.2.1.7. Others
13.6.3.2.2. Secondary Packaging
13.6.3.2.2.1. Cartoning
13.6.3.2.2.2. Overwrapping
13.6.3.2.2.3. Walleting
13.6.3.2.2.4. Labelling
13.6.3.2.2.5. Kit assembly
13.6.3.2.2.6. Others
13.6.3.3. Spain Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Material
13.6.3.3.1. Plastic
13.6.3.3.1.1. PVC
13.6.3.3.1.2. PE
13.6.3.3.1.3. HDPE
13.6.3.3.1.4. LDPE
13.6.3.3.1.5. PP
13.6.3.3.1.6. Others
13.6.3.3.2. Glass
13.6.3.3.3. Paper
13.6.3.3.4. Others
13.6.3.4. Spain Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By End
User
13.6.3.4.1. Research Laboratories
13.6.3.4.2. Clinical Research Organizations
13.6.3.4.3. Drug Manufacturing Facilities
13.6.3.4.4. Biotechnology Companies
13.6.4. Germany
13.6.4.1. Germany Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Clinical Phase
13.6.4.1.1. Phase 1
13.6.4.1.2. Phase 2
13.6.4.1.3. Phase 3
13.6.4.1.4. Phase 4
13.6.4.2. Germany Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Type
13.6.4.2.1. Primary Packaging
13.6.4.2.1.1. Blistering
13.6.4.2.1.2. Bottling
13.6.4.2.1.3. Pouching
13.6.4.2.1.4. Tubing
13.6.4.2.1.5. Sterile fill finish
13.6.4.2.1.6. Aseptic fill
13.6.4.2.1.7. Others
13.6.4.2.2. Secondary Packaging
13.6.4.2.2.1. Cartoning
13.6.4.2.2.2. Overwrapping
13.6.4.2.2.3. Walleting
13.6.4.2.2.4. Labelling
13.6.4.2.2.5. Kit assembly
13.6.4.2.2.6. Others
13.6.4.3. Germany Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Material
13.6.4.3.1. Plastic
13.6.4.3.1.1. PVC
13.6.4.3.1.2. PE
13.6.4.3.1.3. HDPE
13.6.4.3.1.4. LDPE
13.6.4.3.1.5. PP
13.6.4.3.1.6. Others
13.6.4.3.2. Glass
13.6.4.3.3. Paper
13.6.4.3.4. Others
13.6.4.4. Germany Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By End
User
13.6.4.4.1. Research Laboratories
13.6.4.4.2. Clinical Research Organizations
13.6.4.4.3. Drug Manufacturing Facilities
13.6.4.4.4. Biotechnology Companies
13.6.5. Italy
13.6.5.1. Italy Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Clinical Phase
13.6.5.1.1. Phase 1
13.6.5.1.2. Phase 2
13.6.5.1.3. Phase 3
13.6.5.1.4. Phase 4
13.6.5.2. Italy Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Type
13.6.5.2.1. Primary Packaging
13.6.5.2.1.1. Blistering
13.6.5.2.1.2. Bottling
13.6.5.2.1.3. Pouching
13.6.5.2.1.4. Tubing
13.6.5.2.1.5. Sterile fill finish
13.6.5.2.1.6. Aseptic fill
13.6.5.2.1.7. Others
13.6.5.2.2. Secondary Packaging
13.6.5.2.2.1. Cartoning
13.6.5.2.2.2. Overwrapping
13.6.5.2.2.3. Walleting
13.6.5.2.2.4. Labelling
13.6.5.2.2.5. Kit assembly
13.6.5.2.2.6. Others
13.6.5.3. Italy Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Material
13.6.5.3.1. Plastic
13.6.5.3.1.1. PVC
13.6.5.3.1.2. PE
13.6.5.3.1.3. HDPE
13.6.5.3.1.4. LDPE
13.6.5.3.1.5. PP
13.6.5.3.1.6. Others
13.6.5.3.2. Glass
13.6.5.3.3. Paper
13.6.5.3.4. Others
13.6.5.4. Italy Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By End
User
13.6.5.4.1. Research Laboratories
13.6.5.4.2. Clinical Research Organizations
13.6.5.4.3. Drug Manufacturing Facilities
13.6.5.4.4. Biotechnology Companies
13.6.6. Nordic Countries
13.6.6.1. Nordic Countries Clinical Trial
Packaging Market Revenue (US$ Mn) and
Forecasts, By Clinical Phase
13.6.6.1.1. Phase 1
13.6.6.1.2. Phase 2
13.6.6.1.3. Phase 3
13.6.6.1.4. Phase 4
13.6.6.2. Nordic Countries Clinical Trial
Packaging Market Revenue (US$ Mn) and
Forecasts, By Type
13.6.6.2.1. Primary Packaging
13.6.6.2.1.1. Blistering
13.6.6.2.1.2. Bottling
13.6.6.2.1.3. Pouching
13.6.6.2.1.4. Tubing
13.6.6.2.1.5. Sterile fill finish
13.6.6.2.1.6. Aseptic fill
13.6.6.2.1.7. Others
13.6.6.2.2. Secondary Packaging
13.6.6.2.2.1. Cartoning
13.6.6.2.2.2. Overwrapping
13.6.6.2.2.3. Walleting
13.6.6.2.2.4. Labelling
13.6.6.2.2.5. Kit assembly
13.6.6.2.2.6. Others
13.6.6.3. Nordic Countries Clinical Trial
Packaging Market Revenue (US$ Mn) and
Forecasts, By Material
13.6.6.3.1. Plastic
13.6.6.3.1.1. PVC
13.6.6.3.1.2. PE
13.6.6.3.1.3. HDPE
13.6.6.3.1.4. LDPE
13.6.6.3.1.5. PP
13.6.6.3.1.6. Others
13.6.6.3.2. Glass
13.6.6.3.3. Paper
13.6.6.3.4. Others
13.6.6.4. Nordic Countries Clinical Trial
Packaging Market Revenue (US$ Mn) and Forecasts,
By End User
13.6.6.4.1. Research Laboratories
13.6.6.4.2. Clinical Research Organizations
13.6.6.4.3. Drug Manufacturing Facilities
13.6.6.4.4. Biotechnology Companies
13.6.6.5. Nordic Countries Clinical Trial
Packaging Market Revenue (US$ Mn) and
Forecasts, By Country
13.6.6.5.1. Denmark
13.6.6.5.2. Finland
13.6.6.5.3. Iceland
13.6.6.5.4. Sweden
13.6.6.5.5. Norway
13.6.7. Benelux Union
13.6.7.1. Benelux Union Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Clinical Phase
13.6.7.1.1. Phase 1
13.6.7.1.2. Phase 2
13.6.7.1.3. Phase 3
13.6.7.1.4. Phase 4
13.6.7.2. Benelux Union Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Type
13.6.7.2.1. Primary Packaging
13.6.7.2.1.1. Blistering
13.6.7.2.1.2. Bottling
13.6.7.2.1.3. Pouching
13.6.7.2.1.4. Tubing
13.6.7.2.1.5. Sterile fill finish
13.6.7.2.1.6. Aseptic fill
13.6.7.2.1.7. Others
13.6.7.2.2. Secondary Packaging
13.6.7.2.2.1. Cartoning
13.6.7.2.2.2. Overwrapping
13.6.7.2.2.3. Walleting
13.6.7.2.2.4. Labelling
13.6.7.2.2.5. Kit assembly
13.6.7.2.2.6. Others
13.6.7.3. Benelux Union Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Material
13.6.7.3.1. Plastic
13.6.7.3.1.1. PVC
13.6.7.3.1.2. PE
13.6.7.3.1.3. HDPE
13.6.7.3.1.4. LDPE
13.6.7.3.1.5. PP
13.6.7.3.1.6. Others
13.6.7.3.2. Glass
13.6.7.3.3. Paper
13.6.7.3.4. Others
13.6.7.4. Benelux Union Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By End
User
13.6.7.4.1. Research Laboratories
13.6.7.4.2. Clinical Research Organizations
13.6.7.4.3. Drug Manufacturing Facilities
13.6.7.4.4. Biotechnology Companies
13.6.7.5. Benelux Union Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Country
13.6.7.5.1. Belgium
13.6.7.5.2. The Netherlands
13.6.7.5.3. Luxembourg
13.6.8. Rest of Europe
13.6.8.1. Rest of Europe Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Clinical Phase
13.6.8.1.1. Phase 1
13.6.8.1.2. Phase 2
13.6.8.1.3. Phase 3
13.6.8.1.4. Phase 4
13.6.8.2. Rest of Europe Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Type
13.6.8.2.1. Primary Packaging
13.6.8.2.1.1. Blistering
13.6.8.2.1.2. Bottling
13.6.8.2.1.3. Pouching
13.6.8.2.1.4. Tubing
13.6.8.2.1.5. Sterile fill finish
13.6.8.2.1.6. Aseptic fill
13.6.8.2.1.7. Others
13.6.8.2.2. Secondary Packaging
13.6.8.2.2.1. Cartoning
13.6.8.2.2.2. Overwrapping
13.6.8.2.2.3. Walleting
13.6.8.2.2.4. Labelling
13.6.8.2.2.5. Kit assembly
13.6.8.2.2.6. Others
13.6.8.3. Rest of Europe Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Material
13.6.8.3.1. Plastic
13.6.8.3.1.1. PVC
13.6.8.3.1.2. PE
13.6.8.3.1.3. HDPE
13.6.8.3.1.4. LDPE
13.6.8.3.1.5. PP
13.6.8.3.1.6. Others
13.6.8.3.2. Glass
13.6.8.3.3. Paper
13.6.8.3.4. Others
13.6.8.4. Rest of Europe Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By End
User
13.6.8.4.1. Research Laboratories
13.6.8.4.2. Clinical Research Organizations
13.6.8.4.3. Drug Manufacturing Facilities
13.6.8.4.4. Biotechnology Companies
13.7. Key Segment for Channeling Investments
13.7.1. By Country
13.7.2. By Clinical Phase
13.7.3. By Type
13.7.4. By Material
13.7.5. By End User
14. Asia Pacific Clinical Trial Packaging Market Analysis and Forecasts, 2023 - 2031
14.1. Overview
14.1.1. Asia Pacific Clinical Trial Packaging Market Revenue (US$ Mn)
14.2. Asia Pacific Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Clinical Phase
14.2.1. Phase 1
14.2.2. Phase 2
14.2.3. Phase 3
14.2.4. Phase 4
14.3. Asia Pacific Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Type
14.3.1. Primary Packaging
14.3.1.1. Blistering
14.3.1.2. Bottling
14.3.1.3. Pouching
14.3.1.4. Tubing
14.3.1.5. Sterile fill finish
14.3.1.6. Aseptic fill
14.3.1.7. Others
14.3.2. Secondary Packaging
14.3.2.1. Cartoning
14.3.2.2. Overwrapping
14.3.2.3. Walleting
14.3.2.4. Labelling
14.3.2.5. Kit assembly
14.3.2.6. Others
14.4. Asia Pacific Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Material
14.4.1. Plastic
14.4.1.1. PVC
14.4.1.2. PE
14.4.1.3. HDPE
14.4.1.4. LDPE
14.4.1.5. PP
14.4.1.6. Others
14.4.2. Glass
14.4.3. Paper
14.4.4. Others
14.5. Asia Pacific Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By End
User
14.5.1. Research Laboratories
14.5.2. Clinical Research Organizations
14.5.3. Drug Manufacturing Facilities
14.5.4. Biotechnology Companies
14.6. Asia Pacific Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Country
14.6.1. China
14.6.1.1. China Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Clinical Phase
14.6.1.1.1. Phase 1
14.6.1.1.2. Phase 2
14.6.1.1.3. Phase 3
14.6.1.1.4. Phase 4
14.6.1.2. China Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Type
14.6.1.2.1. Primary Packaging
14.6.1.2.1.1. Blistering
14.6.1.2.1.2. Bottling
14.6.1.2.1.3. Pouching
14.6.1.2.1.4. Tubing
14.6.1.2.1.5. Sterile fill finish
14.6.1.2.1.6. Aseptic fill
14.6.1.2.1.7. Others
14.6.1.2.2. Secondary Packaging
14.6.1.2.2.1. Cartoning
14.6.1.2.2.2. Overwrapping
14.6.1.2.2.3. Walleting
14.6.1.2.2.4. Labelling
14.6.1.2.2.5. Kit assembly
14.6.1.2.2.6. Others
14.6.1.3. China Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Material
14.6.1.3.1. Plastic
14.6.1.3.1.1. PVC
14.6.1.3.1.2. PE
14.6.1.3.1.3. HDPE
14.6.1.3.1.4. LDPE
14.6.1.3.1.5. PP
14.6.1.3.1.6. Others
14.6.1.3.2. Glass
14.6.1.3.3. Paper
14.6.1.3.4. Others
14.6.1.4. China Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By End
User
14.6.1.4.1. Research Laboratories
14.6.1.4.2. Clinical Research Organizations
14.6.1.4.3. Drug Manufacturing Facilities
14.6.1.4.4. Biotechnology Companies
14.6.2. Japan
14.6.2.1. Japan Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Clinical Phase
14.6.2.1.1. Phase 1
14.6.2.1.2. Phase 2
14.6.2.1.3. Phase 3
14.6.2.1.4. Phase 4
14.6.2.2. Japan Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Type
14.6.2.2.1. Primary Packaging
14.6.2.2.1.1. Blistering
14.6.2.2.1.2. Bottling
14.6.2.2.1.3. Pouching
14.6.2.2.1.4. Tubing
14.6.2.2.1.5. Sterile fill finish
14.6.2.2.1.6. Aseptic fill
14.6.2.2.1.7. Others
14.6.2.2.2. Secondary Packaging
14.6.2.2.2.1. Cartoning
14.6.2.2.2.2. Overwrapping
14.6.2.2.2.3. Walleting
14.6.2.2.2.4. Labelling
14.6.2.2.2.5. Kit assembly
14.6.2.2.2.6. Others
14.6.2.3. Japan Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Material
14.6.2.3.1. Plastic
14.6.2.3.1.1. PVC
14.6.2.3.1.2. PE
14.6.2.3.1.3. HDPE
14.6.2.3.1.4. LDPE
14.6.2.3.1.5. PP
14.6.2.3.1.6. Others
14.6.2.3.2. Glass
14.6.2.3.3. Paper
14.6.2.3.4. Others
14.6.2.4. Japan Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By End
User
14.6.2.4.1. Research Laboratories
14.6.2.4.2. Clinical Research Organizations
14.6.2.4.3. Drug Manufacturing Facilities
14.6.2.4.4. Biotechnology Companies
14.6.3. India
14.6.3.1. India Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Clinical Phase
14.6.3.1.1. Phase 1
14.6.3.1.2. Phase 2
14.6.3.1.3. Phase 3
14.6.3.1.4. Phase 4
14.6.3.2. India Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Type
14.6.3.2.1. Primary Packaging
14.6.3.2.1.1. Blistering
14.6.3.2.1.2. Bottling
14.6.3.2.1.3. Pouching
14.6.3.2.1.4. Tubing
14.6.3.2.1.5. Sterile fill finish
14.6.3.2.1.6. Aseptic fill
14.6.3.2.1.7. Others
14.6.3.2.2. Secondary Packaging
14.6.3.2.2.1. Cartoning
14.6.3.2.2.2. Overwrapping
14.6.3.2.2.3. Walleting
14.6.3.2.2.4. Labelling
14.6.3.2.2.5. Kit assembly
14.6.3.2.2.6. Others
14.6.3.3. India Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Material
14.6.3.3.1. Plastic
14.6.3.3.1.1. PVC
14.6.3.3.1.2. PE
14.6.3.3.1.3. HDPE
14.6.3.3.1.4. LDPE
14.6.3.3.1.5. PP
14.6.3.3.1.6. Others
14.6.3.3.2. Glass
14.6.3.3.3. Paper
14.6.3.3.4. Others
14.6.3.4. India Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By End
User
14.6.3.4.1. Research Laboratories
14.6.3.4.2. Clinical Research Organizations
14.6.3.4.3. Drug Manufacturing Facilities
14.6.3.4.4. Biotechnology Companies
14.6.4. New Zealand
14.6.4.1. New Zealand Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Clinical Phase
14.6.4.1.1. Phase 1
14.6.4.1.2. Phase 2
14.6.4.1.3. Phase 3
14.6.4.1.4. Phase 4
14.6.4.2. New Zealand Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Type
14.6.4.2.1. Primary Packaging
14.6.4.2.1.1. Blistering
14.6.4.2.1.2. Bottling
14.6.4.2.1.3. Pouching
14.6.4.2.1.4. Tubing
14.6.4.2.1.5. Sterile fill finish
14.6.4.2.1.6. Aseptic fill
14.6.4.2.1.7. Others
14.6.4.2.2. Secondary Packaging
14.6.4.2.2.1. Cartoning
14.6.4.2.2.2. Overwrapping
14.6.4.2.2.3. Walleting
14.6.4.2.2.4. Labelling
14.6.4.2.2.5. Kit assembly
14.6.4.2.2.6. Others
14.6.4.3. New Zealand Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Material
14.6.4.3.1. Plastic
14.6.4.3.1.1. PVC
14.6.4.3.1.2. PE
14.6.4.3.1.3. HDPE
14.6.4.3.1.4. LDPE
14.6.4.3.1.5. PP
14.6.4.3.1.6. Others
14.6.4.3.2. Glass
14.6.4.3.3. Paper
14.6.4.3.4. Others
14.6.4.4. New Zealand Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By End
User
14.6.4.4.1. Research Laboratories
14.6.4.4.2. Clinical Research Organizations
14.6.4.4.3. Drug Manufacturing Facilities
14.6.4.4.4. Biotechnology Companies
14.6.5. Australia
14.6.5.1. Australia Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Clinical Phase
14.6.5.1.1. Phase 1
14.6.5.1.2. Phase 2
14.6.5.1.3. Phase 3
14.6.5.1.4. Phase 4
14.6.5.2. Australia Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Type
14.6.5.2.1. Primary Packaging
14.6.5.2.1.1. Blistering
14.6.5.2.1.2. Bottling
14.6.5.2.1.3. Pouching
14.6.5.2.1.4. Tubing
14.6.5.2.1.5. Sterile fill finish
14.6.5.2.1.6. Aseptic fill
14.6.5.2.1.7. Others
14.6.5.2.2. Secondary Packaging
14.6.5.2.2.1. Cartoning
14.6.5.2.2.2. Overwrapping
14.6.5.2.2.3. Walleting
14.6.5.2.2.4. Labelling
14.6.5.2.2.5. Kit assembly
14.6.5.2.2.6. Others
14.6.5.3. Australia Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Material
14.6.5.3.1. Plastic
14.6.5.3.1.1. PVC
14.6.5.3.1.2. PE
14.6.5.3.1.3. HDPE
14.6.5.3.1.4. LDPE
14.6.5.3.1.5. PP
14.6.5.3.1.6. Others
14.6.5.3.2. Glass
14.6.5.3.3. Paper
14.6.5.3.4. Others
14.6.5.4. Australia Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By End
User
14.6.5.4.1. Research Laboratories
14.6.5.4.2. Clinical Research Organizations
14.6.5.4.3. Drug Manufacturing Facilities
14.6.5.4.4. Biotechnology Companies
14.6.6. South Korea
14.6.6.1. South Korea Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Clinical Phase
14.6.6.1.1. Phase 1
14.6.6.1.2. Phase 2
14.6.6.1.3. Phase 3
14.6.6.1.4. Phase 4
14.6.6.2. South Korea Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Type
14.6.6.2.1. Primary Packaging
14.6.6.2.1.1. Blistering
14.6.6.2.1.2. Bottling
14.6.6.2.1.3. Pouching
14.6.6.2.1.4. Tubing
14.6.6.2.1.5. Sterile fill finish
14.6.6.2.1.6. Aseptic fill
14.6.6.2.1.7. Others
14.6.6.2.2. Secondary Packaging
14.6.6.2.2.1. Cartoning
14.6.6.2.2.2. Overwrapping
14.6.6.2.2.3. Walleting
14.6.6.2.2.4. Labelling
14.6.6.2.2.5. Kit assembly
14.6.6.2.2.6. Others
14.6.6.3. South Korea Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Material
14.6.6.3.1. Plastic
14.6.6.3.1.1. PVC
14.6.6.3.1.2. PE
14.6.6.3.1.3. HDPE
14.6.6.3.1.4. LDPE
14.6.6.3.1.5. PP
14.6.6.3.1.6. Others
14.6.6.3.2. Glass
14.6.6.3.3. Paper
14.6.6.3.4. Others
14.6.6.4. South Korea Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By End
User
14.6.6.4.1. Research Laboratories
14.6.6.4.2. Clinical Research Organizations
14.6.6.4.3. Drug Manufacturing Facilities
14.6.6.4.4. Biotechnology Companies
14.6.7. Southeast Asia
14.6.7.1. Southeast Asia Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Clinical Phase
14.6.7.1.1. Phase 1
14.6.7.1.2. Phase 2
14.6.7.1.3. Phase 3
14.6.7.1.4. Phase 4
14.6.7.2. Southeast Asia Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Type
14.6.7.2.1. Primary Packaging
14.6.7.2.1.1. Blistering
14.6.7.2.1.2. Bottling
14.6.7.2.1.3. Pouching
14.6.7.2.1.4. Tubing
14.6.7.2.1.5. Sterile fill finish
14.6.7.2.1.6. Aseptic fill
14.6.7.2.1.7. Others
14.6.7.2.2. Secondary Packaging
14.6.7.2.2.1. Cartoning
14.6.7.2.2.2. Overwrapping
14.6.7.2.2.3. Walleting
14.6.7.2.2.4. Labelling
14.6.7.2.2.5. Kit assembly
14.6.7.2.2.6. Others
14.6.7.3. Southeast Asia Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Material
14.6.7.3.1. Plastic
14.6.7.3.1.1. PVC
14.6.7.3.1.2. PE
14.6.7.3.1.3. HDPE
14.6.7.3.1.4. LDPE
14.6.7.3.1.5. PP
14.6.7.3.1.6. Others
14.6.7.3.2. Glass
14.6.7.3.3. Paper
14.6.7.3.4. Others
14.6.7.4. Southeast Asia Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By End
User
14.6.7.4.1. Research Laboratories
14.6.7.4.2. Clinical Research Organizations
14.6.7.4.3. Drug Manufacturing Facilities
14.6.7.4.4. Biotechnology Companies
14.6.7.5. Southeast Asia Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Country
14.6.7.5.1. Indonesia
14.6.7.5.2. Thailand
14.6.7.5.3. Malaysia
14.6.7.5.4. Singapore
14.6.7.5.5. Rest of Southeast Asia
14.6.8. Rest of Asia Pacific
14.6.8.1. Rest of Asia Pacific Clinical Trial
Packaging Market Revenue (US$ Mn) and
Forecasts, By Clinical Phase
14.6.8.1.1. Phase 1
14.6.8.1.2. Phase 2
14.6.8.1.3. Phase 3
14.6.8.1.4. Phase 4
14.6.8.2. Rest of Asia Pacific Clinical Trial
Packaging Market Revenue (US$ Mn) and
Forecasts, By Type
14.6.8.2.1. Primary Packaging
14.6.8.2.1.1. Blistering
14.6.8.2.1.2. Bottling
14.6.8.2.1.3. Pouching
14.6.8.2.1.4. Tubing
14.6.8.2.1.5. Sterile fill finish
14.6.8.2.1.6. Aseptic fill
14.6.8.2.1.7. Others
14.6.8.2.2. Secondary Packaging
14.6.8.2.2.1. Cartoning
14.6.8.2.2.2. Overwrapping
14.6.8.2.2.3. Walleting
14.6.8.2.2.4. Labelling
14.6.8.2.2.5. Kit assembly
14.6.8.2.2.6. Others
14.6.8.3. Rest of Asia Pacific Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Material
14.6.8.3.1. Plastic
14.6.8.3.1.1. PVC
14.6.8.3.1.2. PE
14.6.8.3.1.3. HDPE
14.6.8.3.1.4. LDPE
14.6.8.3.1.5. PP
14.6.8.3.1.6. Others
14.6.8.3.2. Glass
14.6.8.3.3. Paper
14.6.8.3.4. Others
14.6.8.4. Rest of Asia Pacific Clinical Trial
Packaging Market Revenue (US$ Mn) and
Forecasts, By End User
14.6.8.4.1. Research Laboratories
14.6.8.4.2. Clinical Research Organizations
14.6.8.4.3. Drug Manufacturing Facilities
14.6.8.4.4. Biotechnology Companies
14.7. Key Segment for Channeling Investments
14.7.1. By Country
14.7.2. By Clinical Phase
14.7.3. By Type
14.7.4. By Material
14.7.5. By End User
15. Middle East and Africa Clinical Trial
Packaging Market Analysis and Forecasts,
2023 - 2031
15.1. Overview
15.1.1. Middle East and Africa Clinical Trial
Packaging Market Revenue (US$ Mn)
15.2. Middle East and Africa Clinical Trial
Packaging Market Revenue (US$ Mn) and
Forecasts, By Clinical Phase
15.2.1. Phase 1
15.2.2. Phase 2
15.2.3. Phase 3
15.2.4. Phase 4
15.3. Middle East and Africa Clinical Trial
Packaging Market Revenue (US$ Mn) and
Forecasts, By Type
15.3.1. Primary Packaging
15.3.1.1. Blistering
15.3.1.2. Bottling
15.3.1.3. Pouching
15.3.1.4. Tubing
15.3.1.5. Sterile fill finish
15.3.1.6. Aseptic fill
15.3.1.7. Others
15.3.2. Secondary Packaging
15.3.2.1. Cartoning
15.3.2.2. Overwrapping
15.3.2.3. Walleting
15.3.2.4. Labelling
15.3.2.5. Kit assembly
15.3.2.6. Others
15.4. Middle East and Africa Clinical Trial
Packaging Market Revenue (US$ Mn) and
Forecasts, By Material
15.4.1. Plastic
15.4.1.1. PVC
15.4.1.2. PE
15.4.1.3. HDPE
15.4.1.4. LDPE
15.4.1.5. PP
15.4.1.6. Others
15.4.2. Glass
15.4.3. Paper
15.4.4. Others
15.5. Middle East and Africa Clinical Trial
Packaging Market Revenue (US$ Mn) and
Forecasts, By End User
15.5.1. Research Laboratories
15.5.2. Clinical Research Organizations
15.5.3. Drug Manufacturing Facilities
15.5.4. Biotechnology Companies
15.6. Middle East and Africa Clinical Trial
Packaging Market Revenue (US$ Mn) and
Forecasts, By Country
15.6.1. Saudi Arabia
15.6.1.1. Saudi Arabia Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Clinical Phase
15.6.1.1.1. Phase 1
15.6.1.1.2. Phase 2
15.6.1.1.3. Phase 3
15.6.1.1.4. Phase 4
15.6.1.2. Saudi Arabia Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Type
15.6.1.2.1. Primary Packaging
15.6.1.2.1.1. Blistering
15.6.1.2.1.2. Bottling
15.6.1.2.1.3. Pouching
15.6.1.2.1.4. Tubing
15.6.1.2.1.5. Sterile fill finish
15.6.1.2.1.6. Aseptic fill
15.6.1.2.1.7. Others
15.6.1.2.2. Secondary Packaging
15.6.1.2.2.1. Cartoning
15.6.1.2.2.2. Overwrapping
15.6.1.2.2.3. Walleting
15.6.1.2.2.4. Labelling
15.6.1.2.2.5. Kit assembly
15.6.1.2.2.6. Others
15.6.1.3. Saudi Arabia Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Material
15.6.1.3.1. Plastic
15.6.1.3.1.1. PVC
15.6.1.3.1.2. PE
15.6.1.3.1.3. HDPE
15.6.1.3.1.4. LDPE
15.6.1.3.1.5. PP
15.6.1.3.1.6. Others
15.6.1.3.2. Glass
15.6.1.3.3. Paper
15.6.1.3.4. Others
15.6.1.4. Saudi Arabia Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By End
User
15.6.1.4.1. Research Laboratories
15.6.1.4.2. Clinical Research Organizations
15.6.1.4.3. Drug Manufacturing Facilities
15.6.1.4.4. Biotechnology Companies
15.6.2. UAE
15.6.2.1. UAE Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Clinical Phase
15.6.2.1.1. Phase 1
15.6.2.1.2. Phase 2
15.6.2.1.3. Phase 3
15.6.2.1.4. Phase 4
15.6.2.2. UAE Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Type
15.6.2.2.1. Primary Packaging
15.6.2.2.1.1. Blistering
15.6.2.2.1.2. Bottling
15.6.2.2.1.3. Pouching
15.6.2.2.1.4. Tubing
15.6.2.2.1.5. Sterile fill finish
15.6.2.2.1.6. Aseptic fill
15.6.2.2.1.7. Others
15.6.2.2.2. Secondary Packaging
15.6.2.2.2.1. Cartoning
15.6.2.2.2.2. Overwrapping
15.6.2.2.2.3. Walleting
15.6.2.2.2.4. Labelling
15.6.2.2.2.5. Kit assembly
15.6.2.2.2.6. Others
15.6.2.3. UAE Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Material
15.6.2.3.1. Plastic
15.6.2.3.1.1. PVC
15.6.2.3.1.2. PE
15.6.2.3.1.3. HDPE
15.6.2.3.1.4. LDPE
15.6.2.3.1.5. PP
15.6.2.3.1.6. Others
15.6.2.3.2. Glass
15.6.2.3.3. Paper
15.6.2.3.4. Others
15.6.2.4. UAE Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By End
User
15.6.2.4.1. Research Laboratories
15.6.2.4.2. Clinical Research Organizations
15.6.2.4.3. Drug Manufacturing Facilities
15.6.2.4.4. Biotechnology Companies
15.6.3. Egypt
15.6.3.1. Egypt Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Clinical Phase
15.6.3.1.1. Phase 1
15.6.3.1.2. Phase 2
15.6.3.1.3. Phase 3
15.6.3.1.4. Phase 4
15.6.3.2. Egypt Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Type
15.6.3.2.1. Primary Packaging
15.6.3.2.1.1. Blistering
15.6.3.2.1.2. Bottling
15.6.3.2.1.3. Pouching
15.6.3.2.1.4. Tubing
15.6.3.2.1.5. Sterile fill finish
15.6.3.2.1.6. Aseptic fill
15.6.3.2.1.7. Others
15.6.3.2.2. Secondary Packaging
15.6.3.2.2.1. Cartoning
15.6.3.2.2.2. Overwrapping
15.6.3.2.2.3. Walleting
15.6.3.2.2.4. Labelling
15.6.3.2.2.5. Kit assembly
15.6.3.2.2.6. Others
15.6.3.3. Egypt Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Material
15.6.3.3.1. Plastic
15.6.3.3.1.1. PVC
15.6.3.3.1.2. PE
15.6.3.3.1.3. HDPE
15.6.3.3.1.4. LDPE
15.6.3.3.1.5. PP
15.6.3.3.1.6. Others
15.6.3.3.2. Glass
15.6.3.3.3. Paper
15.6.3.3.4. Others
15.6.3.4. Egypt Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By End
User
15.6.3.4.1. Research Laboratories
15.6.3.4.2. Clinical Research Organizations
15.6.3.4.3. Drug Manufacturing Facilities
15.6.3.4.4. Biotechnology Companies
15.6.4. Kuwait
15.6.4.1. Kuwait Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Clinical Phase
15.6.4.1.1. Phase 1
15.6.4.1.2. Phase 2
15.6.4.1.3. Phase 3
15.6.4.1.4. Phase 4
15.6.4.2. Kuwait Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Type
15.6.4.2.1. Primary Packaging
15.6.4.2.1.1. Blistering
15.6.4.2.1.2. Bottling
15.6.4.2.1.3. Pouching
15.6.4.2.1.4. Tubing
15.6.4.2.1.5. Sterile fill finish
15.6.4.2.1.6. Aseptic fill
15.6.4.2.1.7. Others
15.6.4.2.2. Secondary Packaging
15.6.4.2.2.1. Cartoning
15.6.4.2.2.2. Overwrapping
15.6.4.2.2.3. Walleting
15.6.4.2.2.4. Labelling
15.6.4.2.2.5. Kit assembly
15.6.4.2.2.6. Others
15.6.4.3. Kuwait Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Material
15.6.4.3.1. Plastic
15.6.4.3.1.1. PVC
15.6.4.3.1.2. PE
15.6.4.3.1.3. HDPE
15.6.4.3.1.4. LDPE
15.6.4.3.1.5. PP
15.6.4.3.1.6. Others
15.6.4.3.2. Glass
15.6.4.3.3. Paper
15.6.4.3.4. Others
15.6.4.4. Kuwait Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By End
User
15.6.4.4.1. Research Laboratories
15.6.4.4.2. Clinical Research Organizations
15.6.4.4.3. Drug Manufacturing Facilities
15.6.4.4.4. Biotechnology Companies
15.6.5. South Africa
15.6.5.1. South Africa Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Clinical Phase
15.6.5.1.1. Phase 1
15.6.5.1.2. Phase 2
15.6.5.1.3. Phase 3
15.6.5.1.4. Phase 4
15.6.5.2. South Africa Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Type
15.6.5.2.1. Primary Packaging
15.6.5.2.1.1. Blistering
15.6.5.2.1.2. Bottling
15.6.5.2.1.3. Pouching
15.6.5.2.1.4. Tubing
15.6.5.2.1.5. Sterile fill finish
15.6.5.2.1.6. Aseptic fill
15.6.5.2.1.7. Others
15.6.5.2.2. Secondary Packaging
15.6.5.2.2.1. Cartoning
15.6.5.2.2.2. Overwrapping
15.6.5.2.2.3. Walleting
15.6.5.2.2.4. Labelling
15.6.5.2.2.5. Kit assembly
15.6.5.2.2.6. Others
15.6.5.3. South Africa Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Material
15.6.5.3.1. Plastic
15.6.5.3.1.1. PVC
15.6.5.3.1.2. PE
15.6.5.3.1.3. HDPE
15.6.5.3.1.4. LDPE
15.6.5.3.1.5. PP
15.6.5.3.1.6. Others
15.6.5.3.2. Glass
15.6.5.3.3. Paper
15.6.5.3.4. Others
15.6.5.4. South Africa Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By End
User
15.6.5.4.1. Research Laboratories
15.6.5.4.2. Clinical Research Organizations
15.6.5.4.3. Drug Manufacturing Facilities
15.6.5.4.4. Biotechnology Companies
15.6.6. Rest of Middle East & Africa
15.6.6.1. Rest of Middle East & Africa Clinical
Trial Packaging Market Revenue (US$ Mn)
and Forecasts, By Clinical Phase
15.6.6.1.1. Phase 1
15.6.6.1.2. Phase 2
15.6.6.1.3. Phase 3
15.6.6.1.4. Phase 4
15.6.6.2. Rest of Middle East & Africa Clinical
Trial Packaging Market Revenue (US$ Mn)
and Forecasts, By Type
15.6.6.2.1. Primary Packaging
15.6.6.2.1.1. Blistering
15.6.6.2.1.2. Bottling
15.6.6.2.1.3. Pouching
15.6.6.2.1.4. Tubing
15.6.6.2.1.5. Sterile fill finish
15.6.6.2.1.6. Aseptic fill
15.6.6.2.1.7. Others
15.6.6.2.2. Secondary Packaging
15.6.6.2.2.1. Cartoning
15.6.6.2.2.2. Overwrapping
15.6.6.2.2.3. Walleting
15.6.6.2.2.4. Labelling
15.6.6.2.2.5. Kit assembly
15.6.6.2.2.6. Others
15.6.6.3. Rest of Middle East & Africa Clinical
Trial Packaging Market Revenue (US$ Mn)
and Forecasts, By Material
15.6.6.3.1. Plastic
15.6.6.3.1.1. PVC
15.6.6.3.1.2. PE
15.6.6.3.1.3. HDPE
15.6.6.3.1.4. LDPE
15.6.6.3.1.5. PP
15.6.6.3.1.6. Others
15.6.6.3.2. Glass
15.6.6.3.3. Paper
15.6.6.3.4. Others
15.6.6.4. Rest of Middle East & Africa Clinical
Trial Packaging Market Revenue (US$ Mn)
and Forecasts, By End User
15.6.6.4.1. Research Laboratories
15.6.6.4.2. Clinical Research Organizations
15.6.6.4.3. Drug Manufacturing Facilities
15.6.6.4.4. Biotechnology Companies
15.7. Key Segment for Channeling Investments
15.7.1. By Country
15.7.2. By Clinical Phase
15.7.3. By Type
15.7.4. By Material
15.7.5. By End User
16. Latin America Clinical Trial Packaging Market Analysis and Forecasts, 2023 - 2031
16.1. Overview
16.1.1. Latin America Clinical Trial Packaging Market Revenue (US$ Mn)
16.2. Latin America Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Clinical Phase
16.2.1. Phase 1
16.2.2. Phase 2
16.2.3. Phase 3
16.2.4. Phase 4
16.3. Latin America Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Type
16.3.1. Primary Packaging
16.3.1.1. Blistering
16.3.1.2. Bottling
16.3.1.3. Pouching
16.3.1.4. Tubing
16.3.1.5. Sterile fill finish
16.3.1.6. Aseptic fill
16.3.1.7. Others
16.3.2. Secondary Packaging
16.3.2.1. Cartoning
16.3.2.2. Overwrapping
16.3.2.3. Walleting
16.3.2.4. Labelling
16.3.2.5. Kit assembly
16.3.2.6. Others
16.4. Latin America Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Material
16.4.1. Plastic
16.4.1.1. PVC
16.4.1.2. PE
16.4.1.3. HDPE
16.4.1.4. LDPE
16.4.1.5. PP
16.4.1.6. Others
16.4.2. Glass
16.4.3. Paper
16.4.4. Others
16.5. Latin America Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By End
User
16.5.1. Research Laboratories
16.5.2. Clinical Research Organizations
16.5.3. Drug Manufacturing Facilities
16.5.4. Biotechnology Companies
16.6. Latin America Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Country
16.6.1. Brazil
16.6.1.1. Brazil Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Clinical Phase
16.6.1.1.1. Phase 1
16.6.1.1.2. Phase 2
16.6.1.1.3. Phase 3
16.6.1.1.4. Phase 4
16.6.1.2. Brazil Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Type
16.6.1.2.1. Primary Packaging
16.6.1.2.1.1. Blistering
16.6.1.2.1.2. Bottling
16.6.1.2.1.3. Pouching
16.6.1.2.1.4. Tubing
16.6.1.2.1.5. Sterile fill finish
16.6.1.2.1.6. Aseptic fill
16.6.1.2.1.7. Others
16.6.1.2.2. Secondary Packaging
16.6.1.2.2.1. Cartoning
16.6.1.2.2.2. Overwrapping
16.6.1.2.2.3. Walleting
16.6.1.2.2.4. Labelling
16.6.1.2.2.5. Kit assembly
16.6.1.2.2.6. Others
16.6.1.3. Brazil Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Material
16.6.1.3.1. Plastic
16.6.1.3.1.1. PVC
16.6.1.3.1.2. PE
16.6.1.3.1.3. HDPE
16.6.1.3.1.4. LDPE
16.6.1.3.1.5. PP
16.6.1.3.1.6. Others
16.6.1.3.2. Glass
16.6.1.3.3. Paper
16.6.1.3.4. Others
16.6.1.4. Brazil Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By End
User
16.6.1.4.1. Research Laboratories
16.6.1.4.2. Clinical Research Organizations
16.6.1.4.3. Drug Manufacturing Facilities
16.6.1.4.4. Biotechnology Companies
16.6.2. Argentina
16.6.2.1. Argentina Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Clinical Phase
16.6.2.1.1. Phase 1
16.6.2.1.2. Phase 2
16.6.2.1.3. Phase 3
16.6.2.1.4. Phase 4
16.6.2.2. Argentina Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Type
16.6.2.2.1. Primary Packaging
16.6.2.2.1.1. Blistering
16.6.2.2.1.2. Bottling
16.6.2.2.1.3. Pouching
16.6.2.2.1.4. Tubing
16.6.2.2.1.5. Sterile fill finish
16.6.2.2.1.6. Aseptic fill
16.6.2.2.1.7. Others
16.6.2.2.2. Secondary Packaging
16.6.2.2.2.1. Cartoning
16.6.2.2.2.2. Overwrapping
16.6.2.2.2.3. Walleting
16.6.2.2.2.4. Labelling
16.6.2.2.2.5. Kit assembly
16.6.2.2.2.6. Others
16.6.2.3. Argentina Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By
Material
16.6.2.3.1. Plastic
16.6.2.3.1.1. PVC
16.6.2.3.1.2. PE
16.6.2.3.1.3. HDPE
16.6.2.3.1.4. LDPE
16.6.2.3.1.5. PP
16.6.2.3.1.6. Others
16.6.2.3.2. Glass
16.6.2.3.3. Paper
16.6.2.3.4. Others
16.6.2.4. Argentina Clinical Trial Packaging Market Revenue (US$ Mn) and Forecasts, By End
User
16.6.2.4.1. Research Laboratories
16.6.2.4.2. Clinical Research Organizations
16.6.2.4.3. Drug Manufacturing Facilities
16.6.2.4.4. Biotechnology Companies
16.6.3. Rest of Latin America
16.6.3.1. Rest of Latin America Clinical Trial
Packaging Market Revenue (US$ Mn) and
Forecasts, By Clinical Phase
16.6.3.1.1. Phase 1
16.6.3.1.2. Phase 2
16.6.3.1.3. Phase 3
16.6.3.1.4. Phase 4
16.6.3.2. Rest of Latin America Clinical Trial
Packaging Market Revenue (US$ Mn) and
Forecasts, By Type
16.6.3.2.1. Primary Packaging
16.6.3.2.1.1. Blistering
16.6.3.2.1.2. Bottling
16.6.3.2.1.3. Pouching
16.6.3.2.1.4. Tubing
16.6.3.2.1.5. Sterile fill finish
16.6.3.2.1.6. Aseptic fill
16.6.3.2.1.7. Others
16.6.3.2.2. Secondary Packaging
16.6.3.2.2.1. Cartoning
16.6.3.2.2.2. Overwrapping
16.6.3.2.2.3. Walleting
16.6.3.2.2.4. Labelling
16.6.3.2.2.5. Kit assembly
16.6.3.2.2.6. Others
16.6.3.3. Rest of Latin America Clinical Trial
Packaging Market Revenue (US$ Mn) and
Forecasts, By Material
16.6.3.3.1. Plastic
16.6.3.3.1.1. PVC
16.6.3.3.1.2. PE
16.6.3.3.1.3. HDPE
16.6.3.3.1.4. LDPE
16.6.3.3.1.5. PP
16.6.3.3.1.6. Others
16.6.3.3.2. Glass
16.6.3.3.3. Paper
16.6.3.3.4. Others
16.6.3.4. Rest of Latin America Clinical Trial
Packaging Market Revenue (US$ Mn) and
Forecasts, By End User
16.6.3.4.1. Research Laboratories
16.6.3.4.2. Clinical Research Organizations
16.6.3.4.3. Drug Manufacturing Facilities
16.6.3.4.4. Biotechnology Companies
16.7. Key Segment for Channeling Investments
16.7.1. By Country
16.7.2. By Clinical Phase
16.7.3. By Type
16.7.4. By Material
16.7.5. By End User
17. Competitive Benchmarking
17.1. Market Share Analysis, 2022
17.2. Global Presence and Growth Strategies
17.2.1. Mergers and Acquisitions
17.2.2. Product Launches
17.2.3. Investments Trends
17.2.4. R&D Initiatives
18. Player Profiles
18.1. 3M
18.1.1. Company Details
18.1.2. Company Overview
18.1.3. Product Offerings
18.1.4. Key Developments
18.1.5. Financial Analysis
18.1.6. SWOT Analysis
18.1.7. Business Strategies
18.2. Almac Group Limited
18.2.1. Company Details
18.2.2. Company Overview
18.2.3. Product Offerings
18.2.4. Key Developments
18.2.5. Financial Analysis
18.2.6. SWOT Analysis
18.2.7. Business Strategies
18.3. Bilcare Limited
18.3.1. Company Details
18.3.2. Company Overview
18.3.3. Product Offerings
18.3.4. Key Developments
18.3.5. Financial Analysis
18.3.6. SWOT Analysis
18.3.7. Business Strategies
18.4. Caligor Coghlan
18.4.1. Company Details
18.4.2. Company Overview
18.4.3. Product Offerings
18.4.4. Key Developments
18.4.5. Financial Analysis
18.4.6. SWOT Analysis
18.4.7. Business Strategies
18.5. Capsugel Belgium NV
18.5.1. Company Details
18.5.2. Company Overview
18.5.3. Product Offerings
18.5.4. Key Developments
18.5.5. Financial Analysis
18.5.6. SWOT Analysis
18.5.7. Business Strategies
18.6. Clinigen Clinical Supplies Management
18.6.1. Company Details
18.6.2. Company Overview
18.6.3. Product Offerings
18.6.4. Key Developments
18.6.5. Financial Analysis
18.6.6. SWOT Analysis
18.6.7. Business Strategies
18.7. Körber AG
18.7.1. Company Details
18.7.2. Company Overview
18.7.3. Product Offerings
18.7.4. Key Developments
18.7.5. Financial Analysis
18.7.6. SWOT Analysis
18.7.7. Business Strategies
18.8. NextPharma Technologies
18.8.1. Company Details
18.8.2. Company Overview
18.8.3. Product Offerings
18.8.4. Key Developments
18.8.5. Financial Analysis
18.8.6. SWOT Analysis
18.8.7. Business Strategies
18.9. PCI Pharma Services
18.9.1. Company Details
18.9.2. Company Overview
18.9.3. Product Offerings
18.9.4. Key Developments
18.9.5. Financial Analysis
18.9.6. SWOT Analysis
18.9.7. Business Strategies
18.10. Piramal Pharma Solutions
18.10.1. Company Details
18.10.2. Company Overview
18.10.3. Product Offerings
18.10.4. Key Developments
18.10.5. Financial Analysis
18.10.6. SWOT Analysis
18.10.7. Business Strategies
18.11. Sharp Services, LLC
18.11.1. Company Details
18.11.2. Company Overview
18.11.3. Product Offerings
18.11.4. Key Developments
18.11.5. Financial Analysis
18.11.6. SWOT Analysis
18.11.7. Business Strategies
18.12. Westrock Company
18.12.1. Company Details
18.12.2. Company Overview
18.12.3. Product Offerings
18.12.4. Key Developments
18.12.5. Financial Analysis
18.12.6. SWOT Analysis
18.12.7. Business Strategies
18.13. Xerimis
18.13.1. Company Details
18.13.2. Company Overview
18.13.3. Product Offerings
18.13.4. Key Developments
18.13.5. Financial Analysis
18.13.6. SWOT Analysis
18.13.7. Business Strategies
18.14. Other Market Participants
19. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User
and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.